We are live on
!
Find out more
Arrowstreet Capital Portfolio holdings
AUM
$185B
1-Year Est. Return
39.58%
This Fund
S&P 500
This Quarter
Est. Return
+10.23%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.68%
AUM
$43B
AUM Growth
+$121M
(+0.28%)
Cap. Flow
-$3.21B
Cap. Flow
% of AUM
-7.47%
Top 10 Holdings %
Top 10 Hldgs %
18.86%
Holding
2,029
New
505
Increased
717
Reduced
446
Closed
331
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$285M |
| 2 |
Applied Materials
AMAT
|
+$234M |
| 3 |
Micron Technology
MU
|
+$185M |
| 4 |
Merck
MRK
|
+$161M |
| 5 |
NXP Semiconductors
NXPI
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$505M |
| 2 |
Bank of America
BAC
|
+$339M |
| 3 |
Nike
NKE
|
+$335M |
| 4 |
Union Pacific
UNP
|
+$329M |
| 5 |
Citigroup
C
|
+$277M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.49% |
| 2 | Financials | 16.82% |
| 3 | Consumer Discretionary | 16.55% |
| 4 | Healthcare | 14.39% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Bio-Rad Laboratories Class A
BIO
$9.39B
| $2.29M | 0.01% |
6,190
-12,807
| -67% | -$4.52M |
|
1102
GE Aerospace
GE
$381B
| $2.29M | 0.01% |
41,128
+31,681
| +335% | +$1.64M |
|
1103
Ceco Environmental
CECO
$3.98B
| $2.27M | 0.01% |
296,258
-23,005
| -7% | -$172K |
|
|
SPTN
1104
DELISTED
SpartanNash
SPTN
| $2.27M | 0.01% |
+159,336
| New | +$2.1M |
|
1105
Spok Holdings
SPOK
$236M
| $2.27M | 0.01% |
185,326
-965
| -0.5% | -$11.4K |
|
1106
Onto Innovation
ONTO
$14.8B
| $2.26M | 0.01% |
+61,883
| New | +$2.1M |
|
1107
Astec Industries
ASTE
$993M
| $2.24M | 0.01% |
+53,355
| New | +$1.94M |
|
1108
Ribbon Communications
RBBN
$372M
| $2.24M | 0.01% |
723,026
+269,826
| +60% | +$1.07M |
|
1109
Fossil Group
FOSL
$329M
| $2.23M | 0.01% |
283,598
-167,167
| -37% | -$1.54M |
|
1110
Yelp
YELP
$1.34B
| $2.21M | 0.01% |
+63,573
| New | +$2.16M |
|
|
VWTR
1111
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $2.21M | 0.01% |
198,908
+8,799
| +5% | +$93.8K |
|
1112
ACM Research
ACMR
$5.68B
| $2.2M | 0.01% |
357,423
| – | – |
|
1113
Digital Turbine
APPS
$1.75B
| $2.19M | 0.01% |
307,105
-190,207
| -38% | -$1.41M |
|
1114
Gossamer Bio
GOSS
$85.9M
| $2.19M | 0.01% |
+139,852
| New | +$2.82M |
|
1115
Westamerica Bancorp
WABC
$1.35B
| $2.19M | 0.01% |
32,238
+11,500
| +55% | +$752K |
|
1116
Star Group
SGU
$418M
| $2.18M | 0.01% |
230,570
-34,500
| -13% | -$324K |
|
|
ORTX
1117
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.17M | 0.01% |
15,788
-1,528
| -9% | -$186K |
|
|
HEP
1118
DELISTED
Holly Energy Partners, L.P.
HEP
| $2.16M | 0.01% |
+97,710
| New | +$2.22M |
|
1119
Rocky Brands
RCKY
$368M
| $2.15M | 0.01% |
73,080
+17,100
| +31% | +$504K |
|
1120
MeiraGTx Holdings
MGTX
$1.21B
| $2.15M | 0.01% |
+107,284
| New | +$1.84M |
|
|
CLCT
1121
DELISTED
Collectors Universe
CLCT
| $2.15M | 0.01% |
93,092
+8,277
| +10% | +$222K |
|
1122
Alphabet (Google) Class A
GOOGL
$4.33T
| $2.14M | 0.01% |
+32,000
| New | +$2.06M |
|
|
BVH
1123
DELISTED
Bluegreen Vacations Holding Corporation
BVH
| $2.14M | 0.01% |
89,759
-11,333
| -11% | -$261K |
|
|
JNPR
1124
DELISTED
Juniper Networks
JNPR
| $2.14M | 0.01% |
+86,900
| New | +$2.14M |
|
1125
Shinhan Financial Group
SHG
$34.7B
| $2.13M | 0.01% |
56,048
+35,223
| +169% | +$1.3M |
|
Similar funds
VGA
Arrowstreet Capital's Q4 2019 Portfolio in Review
As of Q4 2019, Arrowstreet Capital held 2,029 positions worth $43B, up 0.28% from $42.9B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Arrowstreet Capital withdrew a net $3.21B in Q4 2019, closing 331 positions and reducing 446 holdings. Its most notable exit was Celgene Corp, an estimated $505M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Arrowstreet Capital opened a new position in Edwards Lifesciences worth $127M.
- Arrowstreet Capital's largest Q4 2019 buy was Edwards Lifesciences: 1,637,208 shares worth $127M.
- Arrowstreet Capital added most to Intel in Q4 2019, an estimated $285M increase.
- Arrowstreet Capital's biggest Q4 2019 reduction was Union Pacific, cutting an estimated $329M.
- Arrowstreet Capital fully exited Celgene Corp in Q4 2019, selling an estimated $505M.
- Arrowstreet Capital's ten largest holdings make up 19% of its $43B portfolio in Q4 2019.
- Arrowstreet Capital opened 505 new positions and closed 331 in Q4 2019.
- Arrowstreet Capital's portfolio value rose 0.28% quarter-over-quarter to $43B.
Based on Arrowstreet Capital's 13F filing for Q4 2019, filed 13 Feb 2020.